IonQ Sells Out Superion Capacity for 2027 as BofA Trims Its Price Target

IonQ has booked every slot of its Superion-256 quantum system for 2027, and its order book for 2028 is already filling up, the company said — a demand signal that arrives alongside a more cautious note from Wall Street on what that demand is worth.

The capacity news lands as the stock drew an 18% single-day gain on the back of stronger company figures, a move that media reports framed as the market's response to IonQ's revenue surge and its raised full-year outlook. Yet BofA Securities, according to those reports, kept its Buy rating while cutting its price target to $50 from $60, citing a sector-wide contraction in valuation multiples for quantum companies.

That combination — a bullish call on the business paired with a lower valuation framework — captures the tension now shaping how investors read IonQ. The company's operating progress argues in its favor, provided it delivers on the higher revenue expectations it has set. The price the market is willing to pay for that progress is another matter.

A Backlog Split Across Two Businesses

IonQ's remaining performance obligations stand at roughly $1.2 billion. Of that total, $689 million sits in the IonQ Platform business and $479 million in SkyWater, the semiconductor manufacturing operation the company took over. Those contractually committed obligations give IonQ a foundation for future revenue, contingent on meeting the commitments on schedule.

The composition matters for anyone sizing up the backlog. Because the volume is divided between the platform business and the acquired chip fabrication unit, investors need to track not just the headline figure but which segment actually converts its agreed obligations into revenue.

New contracts signed in the third quarter of 2026 add weight to the utilization picture: IonQ closed Platform deals worth about $290 million in the period, with roughly $180 million of that tied to quantum computing.

A Concrete Installation and a Government Pipeline

One date to watch is 2027, when IonQ plans to install a Superion-256 system at Nvidia's research center. The project links demand to a specific deployment — a positive for the growth story as long as IonQ holds to the planned installation window.

Government programs open a second avenue. IonQ has reached Stage C of DARPA's Quantum Benchmarking Initiative, a program that could carry a value of up to $300 million, though funding depends on approvals. For investors in such programs, the key transition is from potential funding levels to appropriated money and executable work.

Already concrete is a DARPA sensor contract worth $28 million covering an initial 25 atomic clocks, with an option for 100 more. That order adds a sensing project with a defined initial delivery scope to the broader demand for quantum systems.

The Loss Picture Sets the Bar

Full capacity meets a company that still needs substantial financing. The adjusted EBITDA loss in the third quarter of 2026 came to $133.6 million. Management expects an improvement in the final quarter versus the prior period but has not given a specific target range.

Operating loss trends therefore carry outsized weight in judging the business. Sold-out capacity strengthens the growth outlook only if additional revenue arrives alongside better cost coverage.

The reported quarterly net profit of $564 million rested mainly on a non-cash mark-to-market gain on warrants. Following its October share issuance, IonQ holds roughly $3.7 billion in liquidity on a pro forma basis — room to execute on the orders it has booked.

Revenue, Guidance and the Price of Growth

The numbers already published give the bullish case its strongest evidence. IonQ reported quarterly revenue of $173.8 million, up 336% year over year. Growth of that magnitude speaks to business momentum, provided it builds a durable base for what comes next.

The next test is the company's own revenue plan. IonQ raised its 2026 guidance to $505 million to $515 million. With sector valuations compressing, hitting that outlook would anchor the positive view more firmly in actual results, and the $1.2 billion backlog offers further support — so long as it turns into revenue.

For now the operating arguments outweigh the valuation concerns, as long as IonQ meets its raised expectations. The pressure on multiples across the sector still demands discipline in that judgment. The most convincing follow-through to the recent rally would be a business performance that withstands the higher bar — and that is the measure by which confidence in IonQ should be judged.